CENTOGENE Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Target Discovery...InSilico Medicine
Prof. Dr. med. Thomas Tüting (right) together with his research team...Otto-von-Guericke-Universität Magdeburg